Day: June 1, 2020

Miami, Florida, June 01, 2020 (GLOBE NEWSWIRE) — Blue Star Foods Corp. (OTC:BSFC), (“Blue Star”), a sustainable seafood company, announced today its financial results for the quarter ended December 31st, 2019 (“Q4-2019”) and Fiscal Year 2019 (“FY-2019”).Fiscal Year 2019 Financial HighlightsNet Sales. Revenue for the twelve months ended December 31, 2019 decreased 25.9% to $23,829,463 as compared to $32,165,933 for the twelve months ended December 31, 2018. The revenue decrease reflects the Company’s exit from the private label business that accounted for 18% of poundage sold for the 12 months ending December 31, 2019 as compared to 37% for the same period in 2018. The company’s Blue Star and other brands poundage were consistent with the prior year. Also contributing to the reduction in revenue, was a reduction in the commodity...

WHITEHALL, Ohio, June 01, 2020 (GLOBE NEWSWIRE) — Heartland BancCorp, (OTCQX: HLAN), parent company of Heartland Bank, today announced that Pamela Goetting has joined Heartland Bank as SVP, Director of the Northern Kentucky Region. In this new leadership role, Pam will oversee the retail, commercial banking, residential mortgage and treasury management operations at all three branch offices recently acquired in the Victory Community Bank merger.“We are very fortunate to have an accomplished and experienced community banker like Pam join our team to lead Heartland’s expansion into the Northern Kentucky/Cincinnati region,” said G. Scott McComb, Chairman and CEO of Heartland Bank. “Her long-time leadership and philanthropic involvement speaks volumes of her ability to lead our regional team as we enter this vibrant market.”Goetting...

CALGARY, Alberta, June 01, 2020 (GLOBE NEWSWIRE) — News Release – TC Energy Corporation (TSX:TRP) (NYSE:TRP) (TC Energy) announced today that it does not intend to exercise its right to redeem its Cumulative Redeemable First Preferred Shares, Series 3 (Series 3 Shares) and Cumulative Redeemable First Preferred Shares, Series 4 (Series 4 Shares) on June 30, 2020.  As a result, subject to certain conditions:(a)  the holders of Series 3 Shares have the right to choose one of the following options with regard to their shares:to retain any or all of their Series 3 Shares and continue to receive a fixed rate quarterly dividend; orto convert, on a one-for-one basis, any or all of their Series 3 Shares into Series 4 Shares and receive a floating rate quarterly dividend, and(b)  the holders of Series 4 Shares have the right to choose one...

LYON, Frankreich und CAMBRIDGE, Mass., June 01, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Therapien entwickelt, bei denen Arzneimittelwirkstoffe in roten Blutkörperchen eingekapselt werden, kündigt die Präsentation von zwei Postern auf der virtuellen Tagung der American Society of Clinical Oncology (ASCO) 2020 an.1.   „Trial-in-Progress-Poster“ zur laufenden TRYbeCA1-Studie der Phase III (Abstract Nr. TPS4666)TRYbeCA-1 ist eine randomisierte, kontrollierte klinische Studie der Phase III zur Beurteilung von Eryaspase bei der Zweitlinienbehandlung von metastasiertem Bauchspeicheldrüsenkrebs. Für die Studie geplant ist eine Teilnehmerzahl von ungefähr 500 Patienten an ungefähr 100 klinischen Standorten in Europa und...

LIONE, Francia e CAMBRIDGE, Mass., June 01, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), un’azienda biofarmaceutica in fase clinica che sviluppa terapie innovative incapsulando sostanze terapeutiche all’interno dei globuli rossi, annuncia la presentazione di due poster all’American Society of Clinical Oncology (ASCO) 2020 Virtual Meeting.1.   Poster nella sezione Trial in Progress per lo studio TRYbeCA1 di fase 3 in corso (Abstract n. TPS4666)TRYbeCA-1 è uno studio clinico di fase 3 randomizzato controllato, volto a valutare l’eryaspase per il trattamento di seconda linea del carcinoma pancreatico metastatico. Si prevede che allo studio partecipino all’incirca 500 pazienti in circa 100 centri clinici in Europa e negli Stati Uniti. I pazienti idonei sono randomizzati in rapporto 1:1 a ricevere eryaspase...

Denver, CO, June 01, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Mitesco, Inc. (OTCQB: MITI) (the “Company” or “Mitesco”) announced that it has retained Donald Capital, LLC (“Donald”) to support its previously announced $15 million Series A Perpetual Preferred Offering, which pays 10% interest and is expected to be registered under an S-1 registration statement filing in Q3 2020 at $25.00 per share.Donald Capital, LLC will take the position as lead placement agent and book runner. Donald Capital LLC, based in New York City, is a FINRA Member Investment Bank founded in 2019 by senior Wall Street veterans.  Their web site is: https://donaldcapital-ny.com/, and their contact is Alex Hamilton, whose phone number is (914) 806-2066, and email address is: ahamilton@donaldcapital-ny.com.Our Operations and Subsidiaries: MyCare, LLC...

AttachmentGOFORE_1.6_trades

LiiteGOFORE_1.6_trades

LiiteINVEST_1.6_trades

LiiteOVARO_1.6_trades